EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.22.62 | Acquired Immunodeficiency Syndrome |
17265069 |
Caspase-9-dependent pathway to murine germ cell apoptosis: mediation by oxidative stress, BAX, and caspase 2. |
causal interaction therapeutic application unassigned |
1 2 0 |
3.4.22.62 | Acute Kidney Injury |
28849533 |
Protective Effect of Taurine on Mice with Doxorubicin-induced Acute Kidney Injury. |
ongoing research unassigned |
2 0 |
3.4.22.62 | Adenocarcinoma |
18566614 |
Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells. |
ongoing research unassigned |
4 0 |
3.4.22.62 | Adenocarcinoma |
20437871 |
Expression analysis of caspase-6, caspase-9 and BNIP3 in prostate cancer. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 4 0 |
3.4.22.62 | Adenocarcinoma |
21284734 |
Immune clearance gastric carcinoma cells in ascites by activating caspase-9-induced apoptosis. |
diagnostic usage ongoing research unassigned |
3 4 0 |
3.4.22.62 | Adenocarcinoma |
21763329 |
Activity of selenium on cell proliferation, cytotoxicity, and apoptosis and on the expression of CASP9, BCL-XL and APC in intestinal adenocarcinoma cells. |
ongoing research unassigned |
4 0 |
3.4.22.62 | Adenocarcinoma |
22199128 |
Immunohistochemical analysis of cell death pathways in gastrointestinal adenocarcinoma. |
ongoing research unassigned |
3 0 |
3.4.22.62 | Adenocarcinoma |
25275061 |
Protein expression differences between lung adenocarcinoma and squamous cell carcinoma with brain metastasis. |
causal interaction unassigned |
4 0 |
3.4.22.62 | Adenocarcinoma |
25664629 |
Cytotoxic and Antimicrobial Evaluations of Novel Apoptotic and Anti-Angiogenic Spiro Cyclic 2-Oxindole Derivatives of 2-Amino-tetrahydroquinolin-5-one. |
causal interaction ongoing research unassigned |
4 1 0 |
3.4.22.62 | Adenocarcinoma |
26299866 |
[Changes in the number of copies of genetic loci in gastric cancer]. |
diagnostic usage ongoing research unassigned |
3 1 0 |